VYOME HOLDINGS, INC. Shares Authorized
VYOME HOLDINGS, INC. (HIND) had Shares Authorized of 300.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-12
- 2026-06-30: Common Stock, Shares Authorized 300.00M shares.
- 2026-03-31: Common Stock, Shares Authorized 300.00M shares.
- 2025-12-31: Common Stock, Shares Authorized 300.00M shares.
- 2025-09-30: Common Stock, Shares Authorized 300.00M shares.
| Period end | Common Stock, Shares Authorized | Common Stock, Shares Authorized as first filed |
|---|---|---|
| 2026-06-30 | 300.00M shares 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 300.00M shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 300.00M shares 10-Q · filed 2026-08-12 | |
| 2025-09-30 | 300.00M shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 20.00M shares 8-K · filed 2025-09-02 | 300.00M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 300.00M shares 10-Q · filed 2025-05-20 | |
| 2024-12-31 | 300.00M shares 10-K · filed 2026-03-18 | |
| 2024-09-30 | 300.00M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 300.00M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 300.00M shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 300.00M shares 10-K · filed 2025-04-04 | |
| 2023-09-30 | 300.00M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 300.00M shares 10-Q · filed 2023-08-07 | |
| 2023-03-31 | 300.00M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 300.00M shares 10-K · filed 2024-04-01 | |
| 2022-09-30 | 100.00M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 100.00M shares 10-Q · filed 2022-08-19 | |
| 2022-03-31 | 100.00M shares 10-Q · filed 2022-05-23 | |
| 2021-12-31 | 100.00M shares 10-K · filed 2023-04-17 | |
| 2021-09-30 | 100.00M shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 100.00M shares 10-Q · filed 2021-08-16 | |
| 2021-03-31 | 100.00M shares 10-Q · filed 2021-05-12 | |
| 2020-12-31 | 275.00M shares 10-K · filed 2022-04-08 | 100.00M shares 10-K · filed 2021-03-12 |
| 2020-09-30 | 100.00M shares 10-Q · filed 2020-11-06 | |
| 2020-06-30 | 100.00M shares 10-Q · filed 2020-07-30 | |
| 2020-03-31 | 100.00M shares 10-Q · filed 2020-06-19 | |
| 2019-12-31 | 100.00M shares 10-K · filed 2021-03-12 | |
| 2019-09-30 | 100.00M shares 10-Q · filed 2019-11-08 | |
| 2019-07-24 | 100.00M shares 10-K · filed 2021-03-12 | |
| 2019-06-30 | 100.00M shares 10-Q · filed 2019-07-24 | |
| 2019-03-31 | 100.00M shares 10-Q · filed 2019-05-10 | |
| 2018-12-31 | 300.00M shares 10-K · filed 2020-02-27 | 100.00M shares 10-K · filed 2019-02-22 |
| 2018-09-30 | 100.00M shares 10-Q · filed 2018-11-02 | |
| 2018-06-30 | 100.00M shares 10-K · filed 2021-03-12 | |
| 2018-05-31 | 300.00M shares 10-K · filed 2021-03-12 | |
| 2018-03-31 | 300.00M shares 10-Q · filed 2018-05-10 | |
| 2017-12-31 | 300.00M shares 10-K · filed 2019-02-22 | |
| 2017-09-30 | 300.00M shares 10-Q · filed 2017-11-03 | |
| 2017-06-30 | 300.00M shares 10-Q · filed 2017-08-02 | |
| 2017-03-31 | 300.00M shares 10-Q · filed 2017-05-10 | |
| 2016-12-31 | 300.00M shares 10-K · filed 2018-03-05 | |
| 2016-10-12 | 300.00M shares 10-K · filed 2018-03-05 | |
| 2016-09-30 | 45.00M shares 10-Q · filed 2016-11-10 | |
| 2016-04-29 | 45.00M shares 10-Q · filed 2016-11-10 | |
| 2015-12-31 | 35.00M shares 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |